Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of the study is to observe the safety of insulin
detemir (Levemir®) in patients with type 1 and type 2 diabetes patients.